MARKET WIREYahoo Finance • 9h ago
Lease Expansion Could Reshape The Case For PACS Group (PACS) StockYahoo Finance report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
Why PACS Stock dropped -3.76% Today — RQD Quant Desk Flash
$47.81 -3.76% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $47.60
PACS Group Inc. (PACS) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (steady margins, 25% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B • BUY
Cap $7.87B
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on PACS Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is PACS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, PACS Group Inc. (NYSE: PACS) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $47.81 (-3.76% 1D, market cap $7.87B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, PACS ranks #47 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does PACS compare to UHS and ENSG in the Health Care sector?
▼
Within the Health Care sector (Hospital/Nursing Management), PACS carries a Roarable B (74/100 RQD), trailing P/E of 41.1x, gross margin of —, and ROIC of 24.6%. By comparison, UHS (Universal Health Services Inc.) holds a C grade (63/100 RQD, P/E 7.0x, ROIC 14.1%, cap $10.41B) and ENSG (The Ensign Group Inc.) posts a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while PACS leads on capital efficiency (24.6% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for PACS?
▼
Per PACS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002001184), PACS Group Inc. generated $5.29B in revenue (+29.4% YoY), $191.5M in net income, and $166.3M in free cash flow against $5.58B in total assets and $244.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 41x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $47.60 (-0.44%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 3.1% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+7.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PACS)Realized 20D OHLCV Swing Band: ±7.7%
Deterministic 5-Pillar Attribution (74/100 Composite)
🔍 WHY PACS SCORES 74/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+17/20 pts (23% of score)
20D Institutional Volume Accumulation (±7.7% realized swing band)
▲ #2 Bullish Driver: Macro Regime Fit+15/20 pts (20% of score)
FRED Regime × Technicals: 94% of 52W Range • RSI-14 at 63.4 (BULLISH MOMENTUM)
▼ #1 Drag / Risk Factor: Cash Engine Quality13/20 pts (-7 pt drag)
Capital intensity & 5.9% operating margin leave 7 pts on the table
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B-$44.38+7.5% Next Q
66
Q2 (-2Q)Grade B-$47.72+0.3% Next Q
69
Q3 (-1Q)Grade B$47.85-0.1% Next Q
71
CurrentGrade B$47.81+7.3% Hist 90D α
74
Trajectory: B- (66) → B (74)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the PACS Bull Thesis Could Fail
Even with a 74/100 (B) score, PACS faces multiple-compression risk if 41.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Priced at 41x earnings—high expectations leave less room for a lukewarm quarter.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($44.40) or 200D SMA ($39.82) invalidates the momentum regime and cuts Target Base ($51.25) toward Bear Floor ($39.20).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PACS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PACS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PACS Stock dropped -3.76% Today — RQD Quant Desk Flash
PACS Group Inc. (PACS) dropped -3.76% to $47.81, trading at 94% of its 52-week range ($10.31 – $50.38). High-quality cash engine (steady margins, 25% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 94% of its 52-week range ($10.31 – $50.38) with RSI-14 at 63.4 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7.7% around $47.81 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 52% gross margin and $166.3M annual free cash flow.
Live PACS Headlines & Catalysts
MARKET WIREInvesting.com • 12h ago
PACS Group CEO Jason Hulse sells $1.58m in company stockInvesting.com report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
CATALYSTYahoo Finance • 15h ago
PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains?Yahoo Finance report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMoomoo • 18h ago
Have PACS Group Insiders Been Selling Stock?Moomoo report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
CATALYSTSeeking Alpha • 21h ago
PACS Group: Strong Growth Opportunities But The Valuation Is Justified (NYSE:PACS)Seeking Alpha report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREUtah Money Watch • 1d ago
The Co-Founders of Utah's Largest Long-Term Care Firm have Now Led the Largest-Ever BYU Athletics Financial Commitment After Selling Over $725 Million of StockUtah Money Watch report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
CATALYSTkalkine.ca • 1d ago
PACS Group (NYSE:PACS) Stock Rises in a Month on a Raised Outlook and Acquisitionkalkine.ca report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
MARKET WIREVPM • 1d ago
Analysis: Corruption allegations in political ads flood Virginia’s midtermsVPM report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeekingAlpha • 3d ago
What Might The October Job Report Look Like?October jobs report: election and inflation risks, sector winners, and top stock picks in health care, finance, manufacturing, and defense.
MARKET WIREYahoo • 6d ago
PACS Group Schedules Third Quarter 2026 Earnings Release and Conference CallSALT LAKE CITY, October 27, 2026--PACS Group, Inc. (NYSE: PACS) ("PACS" or the "Company") announced today that it intends to report its financial results for the third quarter ended September 30, 2026, on Tuesday, Novemb
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (PACS Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PACS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +47.02%▲ ASCENDING CHANNEL
2026-11-02O $49.06H $49.68L $47.81C $47.81VOL 896.5K
RES: $50.44SUP: $41.37SMA50: $44.40SMA200: $39.82
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PACS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
31.1%/yr Implied 5Y Growth
vs. +29.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on PACS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PACS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PACS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PACS)
Health Care Rank #47 of 1016
⚔️ UHS vs PACS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PACS vs. UHS, ENSG, EHC, NHC)
Industry: Hospital/Nursing Management (14 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, PACS Group Inc. (PACS) ranks #47 by composite RQD confidence (74/100, grade B) and #127 by equity capitalization ($7.87B). Within this direct 5-issuer industry benchmark cohort, UHS leads on earnings valuation at 7.0x trailing P/E, while PACS leads on capital efficiency and profitability with 24.6% ROIC and — gross margin. EHC currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with PACS at 74/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PACS
ACTIVE
PACS Group Inc. | B | 74/100 | 41.1x | — | 24.6% | -3.76% | $7.87B | Benchmark Subject |
| UHS Universal Health Services Inc. | C | 63/100 | 7.0x | — | 14.1% | -0.32% | $10.41B | /uhs-vs-pacs → |
| ENSG The Ensign Group Inc. | B | 72/100 | 31.6x | 20.1% | 18.0% | -2.58% | $10.87B | /ensg-vs-pacs → |
| EHC Encompass Health Corporation | B+ | 77/100 | 22.9x | — | 13.8% | +3.35% | $12.97B | /ehc-vs-pacs → |
| NHC National HealthCare Corporation | B | 73/100 | 27.7x | — | 10.1% | -2.84% | $3.32B | /nhc-vs-pacs → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002001184In its most recent audited fiscal period (FY2025, filed 2025-12-31), PACS Group Inc. (PACS) reported GAAP revenue of $5.29B (+29.4% vs. FY2024 revenue of $4.09B , and +70.0% cumulative change since FY2023) , GAAP net income of $191.5M, operating cash flow of $404.2M, and free cash flow of $166.3M (-9.4% YoY). On the balance sheet, PACS closed FY2025 with $5.58B in total assets against $244.8M in total debt (Altman Z-Score: 2.24, Piotroski F-Score: 9/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $5.29B | $191.5M | $404.2M | $166.3M | $5.58B | $244.8M |
| FY2024 (FY) | 2024-12-31 | $4.09B | $55.8M | $367.3M | $183.4M | $5.24B | $251.0M |
| FY2023 (FY) | 2023-12-31 | $3.11B | $112.9M | $63.7M | -$76.3M | $4.33B | $1.01B |
3. PACS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PACS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, PACS Group Inc. (NYSE: PACS) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $47.81 (-3.76% 1D, market cap $7.87B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 17/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, PACS ranks #47 in composite RQD confidence.
How does PACS compare to UHS and ENSG in the Health Care sector?
Within the Health Care sector (Hospital/Nursing Management), PACS carries a Roarable B (74/100 RQD), trailing P/E of 41.1x, gross margin of —, and ROIC of 24.6%. By comparison, UHS (Universal Health Services Inc.) holds a C grade (63/100 RQD, P/E 7.0x, ROIC 14.1%, cap $10.41B) and ENSG (The Ensign Group Inc.) posts a B grade (72/100 RQD, P/E 31.6x, ROIC 18.0%, cap $10.87B). Among the 5-stock peer group, UHS leads on earnings multiple (7.0x) while PACS leads on capital efficiency (24.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PACS?
Per PACS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002001184), PACS Group Inc. generated $5.29B in revenue (+29.4% YoY), $191.5M in net income, and $166.3M in free cash flow against $5.58B in total assets and $244.8M in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Priced at 41x earnings—high expectations leave less room for a lukewarm quarter.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PACS trading relative to its 50-day, 200-day, and 52-week technical levels?
PACS last traded at $47.81 (-3.76% on volume of 591,344 shares), positioning the stock +7.68% above its 50-day simple moving average ($44.40) and +20.07% above its 200-day simple moving average ($39.82). Across its 52-week range of $10.31 to $50.38, PACS sits at the 93.6% percentile with a 14-day RSI of 63.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.7% ($44.13 to $51.49).
PACS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is PACS stock moving today?
Why PACS Stock dropped -3.76% Today — RQD Quant Desk Flash. High-quality cash engine (steady margins, 25% return on capital) with steady institutional support.
ROARABLE RATING BRIEF • RQD 74/100 (B)
✓ STAGE-C NUMBER FIREWALL VERIFIED
PACS — PACS Group Inc.: What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:17:56Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, PACS scores 74 out of 100, a B grade, labeled "Roarable Buy — Good Risk/Reward." The five pillars are:
- Fundamental Cash Engine (13 / 20): Per the Roarable RQD rating, the pillar cites ROIC of 24.6% and an FCF yield of 2.11%. High return on capital paired with a modest free-cash-flow yield suggests the business earns well on invested capital, but the cash return to a buyer at the current price is comparatively thin.
- Whale 13F Flow (17 / 20): Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. It is the highest-scoring pillar, indicating institutional demand as a supportive factor.
- Insider Conviction (15 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. The recent news wire also references a CEO stock sale (see Recent Catalysts), so insider signals should be read alongside that item rather than treated as uniformly positive.
- Macro Regime Fit (15 / 20): Per the Roarable RQD rating, beta is 0.95 per the market data section, and the pillar weighs sector sensitivity. A beta near 1.0 implies market-like sensitivity to broad moves rather than a defensive or aggressive profile.
- Forensic Balance Sheet (14 / 20): Per the Roarable RQD rating, this pillar cites Altman Z of 2.24, Piotroski F of 9/9, and Debt/Equity of 0.26. The strong Piotroski reading and moderate leverage support balance-sheet quality.
Investor implications: the valuation tradeoff is central. Per the market data section, trailing P/E is 41.1 and forward P/E is 34.5, so the stock prices in substantial earnings growth. The upside case rests on that growth materializing and on continued institutional demand; the downside risk is that a compressing multiple or softer growth reduces the stock's price even if the operating business remains sound. The rating is a composite of factors, not a forecast of price direction.
Snapshot
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $5287.9M | $309.6M | $191.5M | N/A | $166.3M | $197.0M | $244.8M |
| FY 2024 | $4086.7M | $123.1M | $55.8M | N/A | $183.4M | $157.7M | $251.0M |
| FY 2023 | $3110.1M | $207.8M | $112.9M | N/A | $-76.3M | N/A | $1012.4M |
Per the SEC financials, revenue grew from $3110.1M in FY 2023 to $5287.9M in FY 2025, and net income rose to $191.5M in FY 2025 from $55.8M in FY 2024. Per the market data section, operating margin is 5.9%, net margin is 3.6%, and gross margin is 0%. ROIC is 24.6%. Per the Roarable RQD rating, Altman Z-Score is 2.24 and Piotroski F-Score is 9/9. Per the Roarable RQD rating, debt-to-equity is 0.26, and per the SEC financials, debt declined from $1012.4M in FY 2023 to $244.8M in FY 2025.
Open Questions
- What is the specific content and financial impact of the lease expansion referenced in the news wire?
- What drove the 6.2% share price surge, and was it tied to a company-specific event?
- What is the full scope of insider sales, including the CEO transaction and the co-founder sales, and how do they reconcile with the insider pillar score?
- What explains the gap between FY 2024 and FY 2025 operating income and net income, and how sustainable is FY 2025 earnings power?
- Why is gross margin reported as 0% and EPS reported as N/A for all periods, and how should the trailing P/E of 41.1 be interpreted given those gaps?
PACS Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for PACS Group Inc. (PACS) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 9h ago
Lease Expansion Could Reshape The Case For PACS Group (PACS) Stock Yahoo Finance report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Investing.com • 12h ago
PACS Group CEO Jason Hulse sells $1.58m in company stock Investing.com report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Yahoo Finance • 15h ago
PACS Group, Inc. (PACS) Surges 6.2%: Is This an Indication of Further Gains? Yahoo Finance report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Moomoo • 18h ago
Have PACS Group Insiders Been Selling Stock? Moomoo report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Seeking Alpha • 21h ago
PACS Group: Strong Growth Opportunities But The Valuation Is Justified (NYSE:PACS) Seeking Alpha report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Utah Money Watch • 1d ago
The Co-Founders of Utah's Largest Long-Term Care Firm have Now Led the Largest-Ever BYU Athletics Financial Commitment After Selling Over $725 Million of Stock Utah Money Watch report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST kalkine.ca • 1d ago
PACS Group (NYSE:PACS) Stock Rises in a Month on a Raised Outlook and Acquisition kalkine.ca report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE VPM • 1d ago
Analysis: Corruption allegations in political ads flood Virginia’s midterms VPM report covering PACS Group Inc. (PACS) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
PACS Bull vs. Bear Conversation Board — What's Your Call at $47.81?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PACS 🐻 33% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐂 BULLISH
🎯 Target: $58.62 (+18.0%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is PACS (B • RQD 74/100) a Buy at $49.68?
Welcome to the PACS (PACS Group Inc.) Roar Pit. Current RQD Composite is 74/100 (Roarable Buy — Good Risk/Reward) in Hospital/Nursing Management. Bulls point to capital efficiency (24.6% ROIC), while bears focus on valuation multiple compression (41.1x trailing P/E). Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
MU MultipleCompression Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $38.25 (-23.0%)
Spot @ $49.68 Pump the brakes on PACS — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on PACS, but look at what you are paying: 41.1x trailing P/E with tightening sector spreads. Unless PACS Group Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
TA TapeReader_Pro Verified K Arena Trader 🐂 BULLISH
🎯 Target: $57.63 (+16.0%)
Spot @ $49.68 PACS cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on PACS, the market is fixating on short-term headline noise in Hospital/Nursing Management and ignoring the balance sheet and cash flow trajectory. At $49.68 (52-wk range $10.31 - $50.38), any beat on forward guidance forces shorts and underweight funds to chase.